Arax Advisory Partners’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.7K Buy
+2,107
New +$11.7K ﹤0.01% 4153
2026
Q1
Sell
-1,104
Closed -$5.02K 4306
2025
Q4
$5.02K Buy
1,104
+1,083
+5,157% +$5.56K ﹤0.01% 2847
2025
Q3
$129 Sell
21
-950
-98% -$6.01K ﹤0.01% 3482
2025
Q2
$6.29K Buy
971
+832
+599% +$4.48K ﹤0.01% 2153
2025
Q1
$739 Sell
139
-60
-30% -$410 ﹤0.01% 2420
2024
Q4
$1.67K Buy
199
+170
+586% +$1.31K ﹤0.01% 2049
2024
Q3
$229 Hold
29
﹤0.01% 2502
2024
Q2
$299 Buy
+29
New +$314 ﹤0.01% 2404

Other funds holding TBI

Arax Advisory Partners's TBI Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Trueblue (TBI) in Q2 2026: 2,107 shares worth $14.7K. The stake represents ﹤0.01% of the portfolio and ranks #4153 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in TBI as recently as Q4 2025.

Arax Advisory Partners first reported a position in TBI in Q2 2024 and has held it in 8 quarters since. 114 funds tracked by Wall St. Rank hold TBI as of Q2 2026.

  • Arax Advisory Partners held 2,107 shares of Trueblue worth $14.7K as of Q2 2026.
  • Trueblue was a new Arax Advisory Partners position in Q2 2026.
  • Trueblue made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4153 holding.
  • Arax Advisory Partners first reported a position in Trueblue in Q2 2024 and has held it in 8 quarters since.
  • 114 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.